Attached files
| file | filename |
|---|---|
| S-1/A - AMENDENT NO. 3 - ENDRA Life Sciences Inc. | end_drs.htm |
Exhibit 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
hereby consent to the reference to our firm under the caption
“Experts” and the use of our report dated July 15, 2016
(except for the effect of the restatement discussed in Note 3 to
the financial statements, for which the date is August 4, 2016 and
except for Note 11, as to which the date is December 16, 2016),
which includes an explanatory paragraph regarding the substantial
doubt about the Company’s ability to continue as a going
concern, on the financial statements of Endra Life Sciences Inc.
which appears in this Registration Statement on Form S-1 Amendment
No. 3.
/s/
RBSM LLP
Henderson,
NV
December 16,
2016